Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crystalloids versus colloids for intraoperative goal-directed fluid management
2005-004602-86Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2005
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Volulyte (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Postoperative morbidity, 30-day mortality and 1 more. Started Oct 2005; status: completed.
02
Drugs
Volulyte
Beyond the preview
Go deeper on 2005-004602-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004602-86.